Phagocytosis, inhibit 325 



Phagosomes 1169, 1170, 1331, 1617, 2179 



, expelled from primary 322 



, primary 327 



, secondary 2096 



Pharmaceuticals 464 



Pharmacologic agent/pharmacological agents 12, 349, 617 



test object 1189 



Pharmacological assays/pharmacological properties 11, 210 



836 





evidence. 



classical 





use 464 



2116 





Pharmacologically 1407, 







identic< 



al 

 706, 



2114 



Pharmacology 



703, 704, 



708, 





of hearts 



839 





710, 839, 1818, 1849, 1977, 1991, 2049, 2118, 2123 



Phase, terminal 327 



Phaseolus 915 



Phases 259 



Phenanthrene 173 



Phenethylamine 699 



Phenol 436, 462, 612, 613, 1004 



Phenolic substrate 840 



Phenoloxidase 2132 



__ enzyme 213 3 



Phenols 467 



Phenylalanine 695, 2078, 2140 



Phenylalanyl-methionyl-arginyl-phenylalanine amide 2134 



residue 1496 



Phenylethylamine derivatives 19 79 



Phenylethylamines 700 



Phenylmethane sulphonyl fluoride-inhibited 1718 



Phenyltrimethylammonium 2114 



Philadelphia, Pa. 157, 899, 1339 



Phillips Island, N. C. 1795 



Phosphatase 159, 161 



Phosphatases, acid 2095, 2096 



, alkaline 2095, 2096 



Phosphate/phosphates 87, 159, 161, 356, 535, 1033, 1600, 2031, 2206 



, bound inorganic 2101 



, labeled 159 



regeneration, inorganic 2182 



uptake and release 738 



values high 356 



Phospho glucose isomerase 2231 



Phosphodiesterase inhibitors 836, 838 



Phosphohexose isomerase locus 20 24 

 Phosphorite, biogenic 509 



769 



